AbCellera Biologics Inc. ABCL Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s change in other assets?
- AbCellera Biologics Inc. (ABCL) reported change in other assets of $1.74M in Q1 2026.
- How has AbCellera Biologics Inc.'s change in other assets changed year-over-year?
- AbCellera Biologics Inc.'s change in other assets increased by 123.8% year-over-year, from -$7.32M to $1.74M.
- What is the long-term trend for AbCellera Biologics Inc.'s change in other assets?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s change in other assets has grown at a -3.1% compound annual growth rate (CAGR), from -$18.25M to -$17.15M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.